Literature DB >> 6146373

Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.

R G McCreadie, M Mackie, D H Wiles, A Jorgensen, V Hansen, C Menzies.   

Abstract

Eleven male chronic schizophrenics were given, serially, oral pimozide, fluphenazine, and flupenthixol; the two latter were also given intramuscularly as decanoates in oil. Oral haloperidol was given before and after each drug. Analysis of variance of steady state plasma levels of the different neuroleptics showed considerable within-individual variation in such levels, probably due to differences in absorption and metabolism and between routes of administration. The findings suggest that if a patient fails to respond to one neuroleptic, there may be good pharmacokinetic reasons for switching him to another belonging to a different group, or for giving the same neuroleptic by a different route of administration. The study also showed that previous administration of one neurololeptic may influence the steady state level of another. The various neuroleptics produced different effects on plasma prolactin levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146373     DOI: 10.1192/bjp.144.6.625

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.

Authors:  A G Jolley; S R Hirsch; A McRink; R Manchanda
Journal:  BMJ       Date:  1989-04-15

Review 2.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

3.  The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.

Authors:  Brian D Chapron; Jean C Dinh; Paul C Toren; Andrea Gaedigk; J Steven Leeder
Journal:  Drug Metab Dispos       Date:  2020-08-26       Impact factor: 3.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.